XML 22 R11.htm IDEA: XBRL DOCUMENT v3.4.0.3
Shareholders' Equity
3 Months Ended
Mar. 31, 2016
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Shareholders' Equity

6. Shareholders’ Equity

Equity Compensation Plans

We have a stock plan (the “Stock Plan”) and an inducement stock plan for newly hired employees (the “Inducement Plan”) (collectively, the “Plans”). Under the Plans, stock options to purchase shares of our common stock may be granted with a fixed exercise price that is equal to the fair market value of our common stock on the date of grant. These options have a term of up to 10 years and vest over a predetermined period, generally four years. Incentive stock options granted under the Stock Plan may only be granted to our employees. The Plans also allow for awards of non-qualified stock options, stock appreciation rights, RSAs and unrestricted stock awards, and RSUs. Expense is recorded for performance options over the requisite service periods when achievement of related performance targets are considered to be probable.

Stock-Based Compensation

The estimated fair value of stock-based awards is recognized as compensation expense over the vesting period of the award, net of estimated forfeitures. We estimate forfeitures based on historical experience and expected future activity. The fair value of RSUs is determined based on the number of shares granted and the quoted price of our common stock on the date of grant. The fair value of stock option awards is estimated at the grant date based on the fair value of each vesting tranche as calculated by the Black-Scholes-Merton (“BSM”) option-pricing model. The BSM model requires various highly judgmental assumptions including expected volatility and option life. If any of the assumptions used in the BSM model change significantly, stock-based compensation expense may differ materially in the future from that recorded in the current period. The fair values of our stock option grants were estimated with the following weighted average assumptions:

 

 

Three Months Ended

March 31,

 

 

2016

 

 

2015

 

Dividend yield

 

0

%

 

 

0

%

Expected life

3.4 years

 

 

3.3 years

 

Expected volatility

 

55

%

 

 

53

%

Risk-free interest rate

 

1.1

%

 

 

1.2

%

The impact on our results of operations of stock-based compensation expense for the three month periods ended March 31, 2016 and 2015 was as follows (in thousands, except per share amounts):

 

 

Three Months Ended

March 31,

 

 

2016

 

 

2015

 

Cost of revenue — service

$

138

 

 

$

113

 

Selling, general and administrative

 

249

 

 

 

138

 

Research and development

 

26

 

 

 

13

 

Total stock-based compensation expense

$

413

 

 

$

264

 

Per diluted share

$

0.03

 

 

$

0.02

 

 

Stock Option Activity

The following table summarizes stock option activity under the Plans for the three month period ended March 31, 2016:

 

Stock Options

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Life

(in years)

 

 

Aggregate

Intrinsic

Value

 

Balance at January 1, 2016

 

 

1,778,697

 

 

$

4.43

 

 

 

 

 

 

 

 

 

Granted

 

 

168,775

 

 

 

5.82

 

 

 

 

 

 

 

 

 

Exercised

 

 

(19,081

)

 

 

3.14

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(15,843

)

 

 

5.79

 

 

 

 

 

 

 

 

 

Expired

 

 

(390

)

 

 

4.30

 

 

 

 

 

 

 

 

 

Balance at March 31, 2016

 

 

1,912,158

 

 

$

4.56

 

 

 

7.79

 

 

$

2,918,097

 

Vested and expected to vest at March 31, 2016

 

 

1,776,293

 

 

$

4.47

 

 

 

7.68

 

 

$

2,845,908

 

Exercisable at March 31, 2016

 

 

838,549

 

 

$

3.62

 

 

 

6.23

 

 

$

1,964,768

 

At March 31, 2016, total compensation cost related to stock options granted but not yet recognized was $1,431,216, net of estimated forfeitures. This cost will be amortized on the straight-line method over a weighted-average period of approximately 1.35 years. The following table summarizes certain information about stock options:

 

 

Three Months Ended

March 31,

 

 

2016

 

 

2015

 

Weighted-average grant-date fair value of option

   grants for the period

$

3.06

 

 

$

2.34

 

Options in-the-money at period end

 

1,338,733

 

 

 

1,353,633

 

Aggregate intrinsic value of options exercised

$

49,330

 

 

$

47,880

 

The aggregate intrinsic value represents the difference between the exercise price of the underlying options and the quoted price of our common stock for the number of options that were in-the-money at period end or that were exercised during the period. We issue new shares of common stock upon exercise of stock options.

Restricted Stock Unit Activity

The following table summarizes RSU activity for the three month period ended March 31, 2016:

 

 

Number of

Shares

 

 

Weighted

Average

Grant Date Fair

Value

 

Unvested at January 1, 2016

 

104,463

 

 

$

5.97

 

Granted

 

2,500

 

 

 

5.83

 

Vested

 

(13,408

)

 

 

6.19

 

Forfeited

 

 

 

 

 

Unvested at March 31, 2016

 

93,555

 

 

$

5.94

 

Expected to vest after March 31, 2016

 

83,054

 

 

$

5.91

 

 

At March 31, 2016, total compensation cost related to RSUs granted but not yet recognized was $254,334, net of estimated forfeitures. This cost will be amortized on the straight-line method over a period of approximately 1.26 years.

Common Stock Reserved for Future Issuance

The following table summarizes our shares of common stock reserved for future issuance under the Plans as of March 31, 2016:

 

Stock options outstanding

 

1,912,158

 

RSUs outstanding

 

93,555

 

Stock awards available for future grant

 

865,435

 

Common stock reserved for future issuance

 

2,871,148